Literature DB >> 21633927

Burden of osteoporosis in adults in Korea: a national health insurance database study.

Hyung Jin Choi1, Chan Soo Shin, Yong-Chan Ha, Sunmee Jang, Sun-Mee Jang, Suhyun Jang, Su-Hyun Jang, Chanmi Park, Chan Mi Park, Hyun-Koo Yoon, Seong-Su Lee.   

Abstract

We evaluated the number of osteoporosis patients under treatment and secular trends in 2005-2008 in South Korea. We investigated nationwide data regarding the number of osteoporosis patients under treatment in South Korea using data from the Health Insurance Review and Assesment Service (HIRA), which includes nationwide information [corrected]. Reimbursement records from the HIRA database between 1 January 2004 and 31 December 2008 were investigated. Patients aged ≥30 years old with osteoporosis were identified based on a study-defined algorithm using prescription data and diagnostic codes. During the study periods, the number of patients receiving medical treatment related to osteoporosis increased from 1,034,399 to 1,392,189 for women and from 120,496 to 171,902 for men. The calculated proportion of osteoporosis patients under treatment in the general population over 50 years of age was 6.1% for men and 33.3% for women, and in the general population over 30 years of age was 2.7% for men and 16.6% for woman. More than 40% of patients (59.1% for women; 41.2% for men) were treated with medication indicated only for osteoporosis. About 4-7% of osteoporosis patients had a past medical history suggesting a secondary cause of osteoporosis. More than 80% of all osteoporosis patients were women older than 50 years, reflecting the pronounced burden of osteoporosis among postmenopausal women. This study demonstrated a substantial increasing trend in medical claims related to osteoporosis in 2005-2008 among adults in Korea and a pronounced burden of osteoporosis among postmenopausal women.

Entities:  

Mesh:

Year:  2011        PMID: 21633927     DOI: 10.1007/s00774-011-0280-x

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  12 in total

1.  Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density.

Authors:  Chan Soo Shin; Hyung Jin Choi; Min Joo Kim; Jin Taek Kim; Sung Hoon Yu; Bo Kyeong Koo; Hwa Young Cho; Sun Wook Cho; Sang Wan Kim; Young Joo Park; Hak Chul Jang; Seong Yeon Kim; Nam H Cho
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

2.  Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  A Tenenhouse; L Joseph; N Kreiger; S Poliquin; T M Murray; L Blondeau; C Berger; D A Hanley; J C Prior
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

3.  Bone mineral density of the spine, hip and distal forearm in representative samples of the Japanese female population: Japanese Population-Based Osteoporosis (JPOS) Study.

Authors:  M Iki; S Kagamimori; Y Kagawa; T Matsuzaki; H Yoneshima; F Marumo
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Proximal femur bone mineral levels of US adults.

Authors:  A C Looker; H W Wahner; W L Dunn; M S Calvo; T B Harris; S P Heyse; C C Johnston; R L Lindsay
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

5.  Bone mineral density at the hip in Norwegian women and men--prevalence of osteoporosis depends on chosen references: the Tromsø Study.

Authors:  Nina Emaus; Tone K Omsland; Luai Awad Ahmed; Guri Grimnes; Monica Sneve; Gro K Berntsen
Journal:  Eur J Epidemiol       Date:  2009-03-19       Impact factor: 8.082

6.  Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.

Authors:  Eva L Ribom; Osten Ljunggren; Hans Mallmin
Journal:  J Clin Densitom       Date:  2008-02-15       Impact factor: 2.617

7.  A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Caucasian women.

Authors:  X P Wu; E Y Liao; G Huang; R C Dai; H Zhang
Journal:  Calcif Tissue Int       Date:  2003-08       Impact factor: 4.333

8.  Determination of age-specific bone mineral density and comparison of diagnosis and prevalence of primary osteoporosis in Chinese women based on both Chinese and World Health Organization criteria.

Authors:  Xian-Ping Wu; Er-Yuan Liao; Hong Zhang; Ru-Chun Dai; Peng-Fei Shan; Xing-Zhi Cao; Shi-Ping Liu; Yebin Jiang
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

9.  Osteoporosis: prevalence in Taiwanese women.

Authors:  Tzay-Shing Yang; Yue-Rong Chen; Yi-Jen Chen; Cheng-Yen Chang; Heung-Tat Ng
Journal:  Osteoporos Int       Date:  2004-02-11       Impact factor: 4.507

10.  Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values.

Authors:  Clara Gram Gjesdal; Sylvi J Aanderud; Hans-Jacob Haga; Johan G Brun; Grethe S Tell
Journal:  Osteoporos Int       Date:  2004-07       Impact factor: 4.507

View more
  46 in total

1.  Knowledge on osteoporosis of prescriber according to level of medical institute.

Authors:  Byung-Ho Yoon; Ji-Hoon Baek; Young-Kyun Lee; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

2.  Knowledge on osteoporosis in guardians of hip fracture patients.

Authors:  Ji-Hoon Baek; Young-Kyun Lee; Seok-Woo Hong; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  J Bone Miner Metab       Date:  2013-02-23       Impact factor: 2.626

3.  Aging and direct medical costs of osteoporotic fractures.

Authors:  Eu Gene Kim; Green Bae; Hye-Young Kwon; Hyowon Yang
Journal:  J Bone Miner Metab       Date:  2021-01-08       Impact factor: 2.626

4.  Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry.

Authors:  Y-K Lee; Y-C Ha; C Park; J J Yoo; C S Shin; K-H Koo
Journal:  Osteoporos Int       Date:  2012-05-23       Impact factor: 4.507

5.  A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians.

Authors:  Sung Ok Hong; Chae-Yoon Lee; Junho Jung; Deog-Yoon Kim; Christian Walter; Yong-Dae Kwon
Journal:  Clin Oral Investig       Date:  2016-10-22       Impact factor: 3.573

6.  Gender- and age-group-specific associations between physical performance and bone mineral density, falls, and osteoporotic fractures in Koreans: the Chungju Metabolic Disease Cohort study.

Authors:  Yejee Lim; Kyunghee Kim; Sun-Hee Ko; Kwanhoon Cho; Eun-Hee Jang; Seung-Hwan Lee; Dong Jun Lim; Ki Hyun Baek; Hee-Sung Ha; Mi Sun Park; Hyeon-Woo Yim; Won-Chul Lee; Kun-Ho Yoon; Ho Young Son; Ki Won Oh; Moo-Il Kang
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

7.  Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women.

Authors:  Sun Min Oh; Byung-Ho Nam; Yumie Rhee; Seong-Hwan Moon; Deog Young Kim; Dae Ryong Kang; Hyeon Chang Kim
Journal:  J Bone Miner Metab       Date:  2013-02-19       Impact factor: 2.626

8.  Bisphosphonate use and subsequent hip fracture in South Korea.

Authors:  Y-K Lee; Y-C Ha; H J Choi; S Jang; C Park; Y-T Lim; C S Shin
Journal:  Osteoporos Int       Date:  2013-05-17       Impact factor: 4.507

9.  Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report.

Authors:  Jeong Keun Lee; Kyung-Wook Kim; Jin-Young Choi; Seong-Yong Moon; Su-Gwan Kim; Chul-Hwan Kim; Hyeon-Min Kim; Yong-Dae Kwon; Yong-Deok Kim; Dong-Keun Lee; Seung-Ki Min; In-Sook Park; Young-Wook Park; Min-Suk Kook; Hong-Ju Park; Jin-A Baek; Jun-Woo Park; Tae-Geon Kwon
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2013-02-21

10.  Current trends and future projections of hip fracture in South Korea using nationwide claims data.

Authors:  Y-C Ha; T-Y Kim; A Lee; Y-K Lee; H-Y Kim; J-H Kim; C-M Park; S Jang
Journal:  Osteoporos Int       Date:  2016-04-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.